Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
08/2000
08/24/2000WO2000010536A9 Extended release buccal bioadhesive tablet
08/24/2000WO1998024898A3 Therapeutic composition comprising the kal protein and use of the kal protein
08/24/2000DE19908753A1 Oligomer-polymer composition containing biodegradable polymers of hydroxycarboxylic acids, useful as injectable implant for administration of various drugs
08/24/2000DE19907874A1 New N-substituted hexahydro-2,6-methano-3-benzazocin-10-ol derivatives, as tension-dependent sodium channel blockers useful for treating e.g. arrhythmia, spasms, pain or neurodegenerative diseases
08/24/2000DE19907385A1 New 3-(phenoxy or phenylalkoxy)-2-phenyl-propylamines, useful for treating e.g. arrhythmia, spasms, pain or neurodegenerative diseases, are tension-dependent sodium channel blockers
08/24/2000DE19906978A1 Treating drug dependence and/or addiction, e.g. due to cocaine or heroin, using desoxypeganine as choline esterase inhibitor and monoamine oxidase inhibitor which crosses blood-brain barrier
08/24/2000DE19906975A1 Treating Alzheimer's dementia, especially by improving cognitive ability, using desoxypeganine as choline esterase inhibitor and monoamine oxidase inhibitor
08/24/2000CA2371872A1 Methods and compositions for regulating protein-protein interactions
08/24/2000CA2363695A1 Dopamine d1 receptor agonist compounds
08/24/2000CA2362943A1 Pyk2 binding proteins
08/24/2000CA2362860A1 Immobilized labeling compounds and methods
08/24/2000CA2362538A1 Secreted proteins and polynucleotides encoding them
08/24/2000CA2362300A1 Human lipid-associated proteins
08/24/2000CA2362290A1 Novel amide derivatives as growth hormone secretagogues
08/24/2000CA2361390A1 Aroyl aminoacyl pyrroles for use in the treatment of neuropathic pain
08/23/2000EP1029872A1 Piperazine-cyclodextrin complexes
08/23/2000EP1029870A2 Hybrid Immunoglobulins
08/23/2000EP1029861A1 Benzisothiazol-piperazinyl derivative and its use as neuroleptic
08/23/2000EP1028975A1 Artemin, a novel neurotrophic factor
08/23/2000EP1028974A1 Secreted proteins and polynucleotides encoding them
08/23/2000EP1028971A2 Novel conjugates of rgd-containing peptides and endogenous carriers
08/23/2000EP1028958A1 Arylpiperazines as serotonin reuptake inhibitors and 5-ht1d alpha antagonists
08/23/2000EP1028957A1 Piperidine derivatives and their use as tachykinin antagonists
08/23/2000EP1028956A1 Imidazoylalkyl substituted with a five, six or seven membered heterocyclic ring containing one nitrogen atom
08/23/2000EP1028955A1 Pyrimidinone compounds and pharmaceutical compositions containing them
08/23/2000EP1028951A1 Diaryl-5-alkyl-5-methyl-2(5h)-furanones as selective cyclooxygenase-2 inhibitors
08/23/2000EP1028948A1 Phenyl-alkyl-imidazoles as h3 receptor antagonists
08/23/2000EP1028947A1 H3 receptor ligands of the phenyl-alkyl-imidazoles type
08/23/2000EP1028945A1 Substituted pyridine compounds as anti-inflammatory agents
08/23/2000EP1028941A2 Compounds for the antemortem diagnosis of alzheimer's disease and in vivo imaging and prevention of amyloid deposition
08/23/2000EP1028744A2 Neuronal uses of bmp-11
08/23/2000EP1028735A1 Therapeutic methods comprising use of a neuregulin
08/23/2000EP1028718A2 Extended release formulation containing venlafaxin
08/23/2000EP1028682A1 Transdermal propentofylline compositions for the treatment of alzheimer's disease
08/23/2000EP0821668B1 Derivatives of succinamide and their use as metalloproteinase inhibitor
08/23/2000EP0752860B1 Androstanes and pregnanes for allosteric modulation of gaba receptor
08/23/2000EP0711289B1 Piperazine compounds used in therapy
08/23/2000EP0674642B1 Pyrazolopyrimidines as crf antagonists
08/23/2000EP0584247B1 Compositons for the treatment of chronic fatigue syndrome
08/23/2000CN1264385A Novel 2-(iminomethyl) amino-phenyl derivatives, preparation, application as medicines and compositions containing same
08/23/2000CN1264384A Fused 1,2,4-thiadiazine derivatives, their preparation method and use
08/23/2000CN1264381A 4-aminopyrrole (3,2-d) pyrimidines as neuropeptide Y receptor antagonists
08/23/2000CN1264379A Piperazine derivatives
08/23/2000CN1264378A Quinoline-4-carboxamide derivatives as NK-2 and NK-3 receptor antagonists
08/23/2000CN1264363A Tramadol, salts thereof and process for their preparation
08/23/2000CN1264304A Lipid-based immune modulator composition
08/23/2000CN1263768A Chinese-medicinal oral nerve growth liquid
08/23/2000CN1263763A Drug composition containing carboxyl oxime acide derivative
08/23/2000CN1055700C Therapeutic peptide derivatives
08/23/2000CN1055690C 4-aryloxy-and-4-arylthiopiperidine derivatives, method for preparation them, medicine compound containing them and use thereof
08/23/2000CN1055687C Novel piperazine carboxamides
08/23/2000CN1055641C Method of enhancing mental function
08/23/2000CN1055619C Health-care cigarette plaster and preparation method thereof
08/22/2000US6107473 Kringle-related clone HTHBZ47
08/22/2000US6107345 Antidepressant; psychological disorders
08/22/2000US6107342 2-amino-bicyclo[3.1.0]hexane-2,6-dicarboxylic acid derivatives and a process for the preparation thereof
08/22/2000US6107331 Use of estrogen antagonists and estrogen agonists in inhibiting pathological conditions
08/22/2000US6107324 5-HT2A receptor inverse agonists
08/22/2000US6107323 Preventing or treating angiotensin diseases by administering an antagonist and compound which increases insulin sensitivity
08/22/2000US6107315 Nervous system disorders
08/22/2000US6107310 Heteroarylcarboxamide derivatives for treating CNS disorders
08/22/2000US6107307 Psychological disorders
08/22/2000US6107305 Antiproferative agent, antiinflammatory agents
08/22/2000US6107300 Arylamino fused pyrimidines
08/22/2000US6107294 Nervous system and psychological disorders
08/22/2000US6107291 Antiinflammatory agent
08/22/2000US6107271 Neuroactive peptides
08/22/2000US6106863 Sustained-release metal valproate tablets
08/22/2000US6106858 Loading active materials of liposomes by dissolving
08/22/2000US6106830 Methods for the treatment of apoptosis-related diseases by batroxobin
08/22/2000US6106822 Hormone and growth factor phosphoglycokine mimetics from mycobacterium
08/22/2000CA2176973C Phenyl heterocycles as cyclooxygenase-2 inhibitors
08/22/2000CA2165992C Disulphides
08/22/2000CA2143246C Imidazodiazepines
08/22/2000CA2085987C Piperidyl-substituted indoles
08/17/2000WO2000047762A2 Enriched central nervous system cell populations
08/17/2000WO2000047723A2 Human diacylglycerol kinase beta (hdagk beta) proteins and nucleotide sequences encoding the same
08/17/2000WO2000047716A2 Fibres for culturing eukaryotic cells
08/17/2000WO2000047625A2 Humanized immunoglobulin reactive with b7 molecules and methods of treatment therewith
08/17/2000WO2000047624A1 Dihydroouabain-like factor and diagnostic and therapeutic compositions and methods
08/17/2000WO2000047619A1 Therapeutics and diagnostics based on an il-1b mutation
08/17/2000WO2000047618A2 HUMAN β-SECRETASE ENZYME, INHIBITORS AND THEIR COMPOSITIONS AND USES
08/17/2000WO2000047615A2 Proteins related to neuronal regeneration and uses thereof
08/17/2000WO2000047603A2 16-hydroxyestratrienes as selective estrogens
08/17/2000WO2000047602A1 33 human secreted proteins
08/17/2000WO2000047583A1 Cyclic substituted fused pyrrolocarbazoles and isoindolones
08/17/2000WO2000047582A1 Triazolo-pyridazine derivatives as ligands for gaba receptors
08/17/2000WO2000047580A2 Phenyl urea and phenyl thiourea derivatives
08/17/2000WO2000047578A1 Heteroaryl amidines, methylamidines and guanidines as protease inhibitors
08/17/2000WO2000047577A1 Phenyl urea and phenyl thiourea derivatives as orexin receptor antagonists
08/17/2000WO2000047576A1 Cinnamide derivatives as orexin-1 receptors antagonists
08/17/2000WO2000047575A1 Pyrrole derivatives and cell death inhibitors
08/17/2000WO2000047573A1 Heterocyclic derivatives as inhibitors of factor xa
08/17/2000WO2000047572A1 (1-phenacy-3-phenyl-3-piperidylethyl)piperidine derivatives, method for the production thereof and pharmaceutical compositions containing the same
08/17/2000WO2000047571A1 Piperidine and piperazine derivatives as inhibitors of the abeta fibril formation
08/17/2000WO2000047567A1 Heterodiazinone derivatives
08/17/2000WO2000047565A1 Pyrimidine-2,4,6-triones as inhibitors of matrix metalloproteinases
08/17/2000WO2000047562A1 Spirocyclic ketones and their use as tachykinin antagonists
08/17/2000WO2000047559A2 5-ht1f agonists
08/17/2000WO2000047284A2 Novel use of orexin receptor antagonists
1 ... 1489 1490 1491 1492 1493 1494 1495 1496 1497 1498 1499 1500 1501 1502 1503 1504 1505 1506 1507 1508 1509 ... 1833